Status:
RECRUITING
Fisetin Supplementation for Healthy Aging
Lead Sponsor:
Ove Andersen
Conditions:
Healthy
Eligibility:
All Genders
50+ years
Phase:
NA
Brief Summary
There is growing interest among the general population in preventive health interventions that can help mitigate age-related decline, reduce the risk of chronic diseases, and promote healthy aging. Th...
Detailed Description
The goal of this study is to assess the anti-inflammatory effects, overall health benefits, and the safety of a daily low dose (100 mg) of fisetin in relatively healthy middle-aged and older adults. ...
Eligibility Criteria
Inclusion
- Middle-aged or older adult (≥50 years),
- Able to cooperate cognitively,
- Able to read and understand Danish,
Exclusion
- Inability or unwillingness to take oral supplements,
- Chronic or recent (within 30 days) use of other anti-aging supplements,
- Chronic or recent (within 30 days) treatment with medications having anti-aging effects (e.g., metformin, rapamycin, semaglutide),
- Chronic or recent (within 30 days) treatment with anti-inflammatory medications,
- Chronic or recent (within 30 days) treatment with the medications that can interact negatively with fisetin,
- Recent (within 14 days) vaccination,
- Treatment with another investigational drug or other intervention within 1 year,
- Active cancer or current cancer treatment,
- Unstable or uncontrolled major disorders, e.g., cardiovascular, renal, endocrine, immunological, hepatic disorder, or cancer, requiring regular monitoring at the hospital
- Planned medical and surgical procedures during the study period,
- Known hypersensitivity or allergy to fisetin or excipients in the placebo capsules,
- Presence of any condition that the investigator believes would put the participant at risk or would preclude the participant from successfully completing all aspects of the study
Key Trial Info
Start Date :
September 24 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 20 2035
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT07195318
Start Date
September 24 2025
End Date
September 20 2035
Last Update
November 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Clinical Research, Copenhagen University Hospital Amager & Hvidovre
Hvidovre, Denmark, 2650